eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.31
-0.22 (-2.88%)
At close: Mar 6, 2026, 4:00 PM EST
7.29
-0.02 (-0.31%)
After-hours: Mar 6, 2026, 4:00 PM EST
eXoZymes Employees
eXoZymes had 31 employees as of December 31, 2024. The number of employees increased by 2 or 6.90% compared to the previous year.
Employees
31
Change (1Y)
2
Growth (1Y)
6.90%
Revenue / Employee
n/a
Profits / Employee
-$269,022
Market Cap
61.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 148 |
| ImmuCell | 84 |
| BeyondSpring | 40 |
| Mereo BioPharma Group | 36 |
| Q32 Bio | 26 |
| NeurAxis | 21 |
| Rallybio | 15 |
| Instil Bio | 14 |
EXOZ News
- 25 days ago - With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation - Accesswire
- 5 weeks ago - eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - Accesswire
- 3 months ago - eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion - Accesswire
- 4 months ago - eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today - Accesswire
- 4 months ago - eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff - Accesswire
- 4 months ago - eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST - Accesswire
- 4 months ago - CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference - Accesswire
- 4 months ago - CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference - Accesswire